Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/01/21
Reata Pharma Shares Are Trading Higher After Filing US Application In Alport Syndrome-Related Kidney DiseaseBenzinga • 03/01/21
Reata Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results and Provides an Update on Clinical Development ProgramsGlobeNewsWire • 03/01/21
Reata Pharmaceuticals, Inc. Submits NDA for Company's Lead Program: Bardoxolone in Alport SyndromeGlobeNewsWire • 03/01/21
Reata Pharmaceuticals, Inc. to Report Fourth Quarter and Full Year 2020 Financials and to Provide an Update on Development Programs on March 1, 2021GlobeNewsWire • 02/22/21
Reata Pharmaceuticals, Inc. (RETA) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 02/10/21
RETA Final Deadline Notice: Rosen, Top Ranked Investor Counsel, Reminds Reata Pharmaceuticals, Inc. Investors of Important Deadline Today in Securities Class Action - RETANewsfile Corp • 12/14/20
RETA FINAL DEADLINE ALERT: ROSEN, TRUSTED AND LEADING INVESTOR COUNSEL, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action - RETAPRNewsWire • 12/12/20
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 12/12/20
IMMINENT DEADLINE Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc. – RETAGlobeNewsWire • 12/11/20
DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/11/20
RETA FINAL DEADLINE: Top Ranked Rosen Law Firm Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action - RETANewsfile Corp • 12/10/20
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/10/20
DEADLINE MONDAY ALERT: The Schall Law Firm Announces it is Investigating Claims Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 12/09/20
DEADLINE FOR RETA INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc.Newsfile Corp • 12/09/20
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/09/20
DEC. 14 DEADINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc.– RETAGlobeNewsWire • 12/08/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/08/20
Rosen, A Top Ranked Law Firm, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - RETANewsfile Corp • 12/07/20
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 12/07/20
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock OfferingGlobeNewsWire • 12/04/20
Zhang Investor Law Alerts Investors to Deadline in Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc. – RETAGlobeNewsWire • 12/03/20
